SCHEMBL931636

SCHEMBL931636

COC(=O)C1CCN(C(=O)OC(C)(C)C)C2=C(C)CC(C)C=C2C1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN6 P29350 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
ALDH1A1 P00352 1/20 0.32
STS P08842 5/20 0.32
ELANE P08246 1/20 0.32
LMNA P02545 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
KDM1A O60341 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL949514 0.90 MAPT (0.37) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL931637 0.83 STS (0.34) PTPN2PTPN1PTPN6PDE4APDE4B
SCHEMBL18039817 0.74 PDE4B (0.46) PTPN2PTPN1PTPN6PDE4APDE4B
SCHEMBL949516 0.73 MAPT (0.37) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL108497 0.71 LMNA (0.38) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL6349458 0.68 GABRA1 (0.40) PDE4APDE4BPDE4CPDE4DKDM1A
SCHEMBL26663735 0.67 PDE4A (0.42) PTPN2PTPN1PTPN6PDE4APDE4B
SCHEMBL26663249 0.67 PDE4B (0.45) PTPN2PTPN1PTPN6PDE4APDE4B
SCHEMBL17459681 0.66 PDE4B (0.47) PTPN2PTPN1PTPN6PDE4APDE4B
SCHEMBL20594536 0.66 PDE4A (0.46) PTPN2PTPN1PTPN6PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448933-A1 TRANS-4-[[(5S)-5-[[[3,5-BIS(TRIFLUOROMETHYL)PHENYL]METHYL](2-METHYL-2H-TETRAZOL-5-YL)AMINO]-2,3,4,5-TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-YL]METHYL]-CYCLOHEXANECARBOXYLIC ACID Eli Lilly and Company (US) 2012-05-09 EP disclosed
WO-2011002696-A1 TRANS-4-[[(5S)-5-[[[3,5-BIS(TRIFLUOROMETHYL)PHENYL]METHYL] (2-METHYL-2H-TETRAZOL-5-YL)AMINO]-2,3,4,5-TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-YL]METHYL]-CYCLOHEXANECARBOXYLIC ACID ELI LILLY AND COMPANY (US) 2011-01-06 WO disclosed